342 related articles for article (PubMed ID: 35517811)
1. Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.
Tempark T; John S; Rerknimitr P; Satapornpong P; Sukasem C
Front Pharmacol; 2022; 13():832048. PubMed ID: 35517811
[TBL] [Abstract][Full Text] [Related]
2. Genotyping
Jantararoungtong T; Tempark T; Koomdee N; Medhasi S; Sukasem C
Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1049-1064. PubMed ID: 34148467
[No Abstract] [Full Text] [Related]
3. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Severe Cutaneous Adverse Reactions.
Yang SC; Chen CB; Lin MY; Zhang ZY; Jia XY; Huang M; Zou YF; Chung WH
Front Med (Lausanne); 2021; 8():652091. PubMed ID: 34336873
[TBL] [Abstract][Full Text] [Related]
5. Evolution of
Koomdee N; Kloypan C; Jinda P; Rachanakul J; Jantararoungtong T; Sukprasong R; Prommas S; Nuntharadthanaphong N; Puangpetch A; Ershadian M; John S; Biswas M; Sukasem C
Front Pharmacol; 2022; 13():866903. PubMed ID: 35450046
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
[TBL] [Abstract][Full Text] [Related]
8. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions.
Wang CW; Dao RL; Chung WH
Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):339-45. PubMed ID: 27362322
[TBL] [Abstract][Full Text] [Related]
11. Genetic Determinants in
Ahmed AF; Sukasem C; Sabbah MA; Musa NF; Mohamed Noor DA; Daud NAA
J Pers Med; 2021 May; 11(5):. PubMed ID: 34067134
[TBL] [Abstract][Full Text] [Related]
12. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population.
Tempark T; Satapornpong P; Rerknimitr P; Nakkam N; Saksit N; Wattanakrai P; Jantararoungtong T; Koomdee N; Mahakkanukrauh A; Tassaneeyakul W; Suttisai S; Pratoomwun J; Klaewsongkram J; Rerkpattanapipat T; Sukasem C
Pharmacogenet Genomics; 2017 Dec; 27(12):429-437. PubMed ID: 28885988
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children.
Manuyakorn W; Likkasittipan P; Wattanapokayakit S; Suvichapanich S; Inunchot W; Wichukchinda N; Khongkhatithuml C; Thampratankul L; Kamchaisatian W; Benjaponpitak S; Mahasirimongkol S
Epilepsy Res; 2020 May; 162():106321. PubMed ID: 32272329
[TBL] [Abstract][Full Text] [Related]
14. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
15. HLA Association with Drug-Induced Adverse Reactions.
Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach.
Sanabria-Cabrera J; Medina-Cáliz I; Stankevičiūtė S; Rodríguez-Nicolás A; Almarza-Torres M; Lucena MI; Andrade RJ
Curr Pharm Des; 2019; 25(36):3855-3871. PubMed ID: 31696806
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.
Saksit N; Tassaneeyakul W; Nakkam N; Konyoung P; Khunarkornsiri U; Chumworathayi P; Sukasem C; Suttisai S; Piriyachananusorn N; Tiwong P; Chaiyakunapruk N; Sawanyawisuth K; Rerkpattanapipat T; Tassaneeyakul W
Pharmacogenet Genomics; 2017 Jul; 27(7):255-263. PubMed ID: 28509689
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
[No Abstract] [Full Text] [Related]
19. Comparison between the
Saksit N; Nakkam N; Konyoung P; Khunarkornsiri U; Tassaneeyakul W; Chumworathayi P; Kanjanawart S; Sukasem C; Sangviroon A; Pattanacheewapull O; Tassaneeyakul W
J Immunol Res; 2017; 2017():2738784. PubMed ID: 29392141
[TBL] [Abstract][Full Text] [Related]
20. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
